Connect with us


More on Multiple Sclerosis MS CBD Treatment



Through the process of research on CBD and its vast array of effects on human physiology, health, and well-being, we have found that it is worth pursuing on a level that has rarely been found in nature. While it is not a cure of everything, it is unquestionably a very rare substance that has extraordinary potential to improve the human condition.

If one were to attempt to factor out why CBD has such a widespread impact on such a wide variety of health conditions, this attempt would no doubt be rooted in a process of understanding how homeostasis is core to human physiological health. In other words, CBD tends to be effective at dealing with conditions that result from an imbalance of some particular systematic function in the human physiological system.

Another shorthand way of stating all of this is simply: CBD promotes homeostasis.

Today, we’re going to take a look at how CBD can be effective in treating some of the elements of symptomology associated with multiple sclerosis, or MS.

Understanding Spasticity

When muscle fibers become tense for a prolonged duration in the skeleto-muscular system, we call this “spasticity”. This condition is occasionally accompanied by acute spasms of the muscle tissue, and as you can imagine, can make everyday life a series of nearly impossible tasks. This can impinge itself upon such simple things as walking, talking, brushing your hair, or putting on shoes.

Spasticity is a condition associated with stroke, cerebral palsy, and MS. In each case, spasticity is driven by a variant causality, which obfuscates treatment programs in practice by the medical establishment.

The key to understand here is as follows: spasticity occurs when there is a lesion on the motor cortex, which is an area of the central nervous system that sends strong impulses downward through spinal pathways and into muscle fibers to inspire voluntary movement of the body.

Such lesions can be caused by stroke, cerebral palsy, or the demyelination associated with multiple sclerosis.

Demyelination, Spasticity, and CBD

Demyelination is effectively the degradation of the myelin sheath that coats or covers the very many axons found in the neuronal system of the human body. To understand exactly what an axon is, think of a cable cord that carries the signal from your cable company to your television. Of course, the axon is about 1 billion times shorter, but probably more reliable.

When the coating of the myelin sheath has worn away or disappeared, the nerve cell becomes exposed to externalities and eventually becomes damaged. Multiple sclerosis, or MS, is defined by the erosion of this myelin sheath material, and therefore the resultant nerve damage.

Much of this process of damage and erosion is related to dysfunction in the anti-inflammatory response mechanisms of the body. In effect, one can think of this process as the body battling against itself under the false premise that the myelin sheath coating of the nerve cells is an attacking pathogen. The immune system gets to work, firing up its T cell foot soldiers, and the negative symptomology associated with MS ensues.

However, CBD can be a strong tool in the fight to counter these forces. As we have found through anecdotal and scientific research, CBD is a strong neuroprotective agent that can help to provide extra protection to exposed nerve cells. It is also a powerful antioxidant that can prevent further aggravation to the immune system.

These strong systemic impacts, taken with CBD’s natural anxiolytic and palliative tendencies, make it a powerful tool as we construct our defenses against this terrible disease.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories